IPIX Milestones, Clinical Trials, Recent Articles,

New Post Public Reply Private Reply Replies (0) Message Board
sox0407
630
IPIX Milestones, Clinical Trials, Recent Articles, Corporate Overview, Patents

Upcoming Milestones

[ygfdBiocentury_slide_deck_9-8-17.jpg

Past Milestones

Kevetrin

- Highly encouraging preliminary data (Phase 2a)
http://www.ipharminc.com/press-release/2017/1...ncer-trial

- Positive primary endpoint and p21 data (Phase 1)
http://www.ipharminc.com/press-release/2016/1...e-patients

- Orphan drug designation for ovarian cancer
http://www.ipharminc.com/press-release/2016/1...ian-cancer

- Orphan drug designation for pancreatic cancer
http://www.ipharminc.com/press-release/2016/1...tic-cancer

- Orphan drug designation for retinoblastoma
http://www.ipharminc.com/press-release/2016/1...noblastoma

- Rare pediatric disease designation for retinoblastoma
http://www.ipharminc.com/press-release/2016/1...noblastoma

Brilacidin

- B-OM positive top-line data (Phase 2)
http://www.ipharminc.com/press-release/2017/1...r-patients

- B-UP positive top-line data (Phase 2 POC)
http://www.ipharminc.com/press-release/2017/7...brilacidin

- B-ABSSSI positive top-line data (Phase 2b)
http://www.ipharminc.com/press-release/2016/1...daptomycin

- QIDP designation for B-ABSSSI
http://www.ipharminc.com/press-release/2016/1...n-from-fda

- Fast track designation for B-OM
http://www.ipharminc.com/press-release/2016/1...-mucositis

- MTA extension for prophylactic testing in implanted devices
http://www.ipharminc.com/press-release/2016/1...infections

- Formulation stable at room temperature
http://www.ipharminc.com/press-release/2016/1...oot-ulcers

- American Society for Microbiology journal publication
http://aac.asm.org/content/early/2014/06/11/A...#corresp-1

Prurisol

- Positive top-line data (Phase 2a)
http://www.ipharminc.com/press-release/2016/1...y-endpoint

- Positive primary endpoint (Phase 1)
http://www.ipharminc.com/press-release/2016/1...ical-trial

- 505(b)(2) pathway
http://www.ipharminc.com/press-release/2016/1...iasis-drug

Clinical Trials

1. K-OC (Phase 2a, Recruiting )
https://clinicaltrials.gov/ct2/show/NCT030427...amp;rank=1

2. P (Phase 1, Completed )
https://clinicaltrials.gov/ct2/show/NCT021012...amp;rank=2

3. B-OM (Phase 2, Completed )
https://clinicaltrials.gov/ct2/show/NCT023243...amp;rank=3

4. P (Phase 2a, Completed )
https://clinicaltrials.gov/ct2/show/NCT024944...amp;rank=4

5. P (Phase 2b, Active, not recruiting )
https://clinicaltrials.gov/ct2/show/NCT029493...amp;rank=5

6. B-ABSSSI (Phase 2b, Completed )
https://clinicaltrials.gov/ct2/show/NCT020523...amp;rank=6

7. K (Phase 1, Completed )
https://clinicaltrials.gov/ct2/show/NCT016640...amp;rank=7

8. B-UP (Phase 2 POC, Completed )
http://www.ipharminc.com/press-release/2016/1...-proctitis

Pipeline



Recent Articles

- A Billion Dollar Market Just Waiting for a New Oral Mucositis Drug: Five Companies That Want It
http://www.baystreet.ca/stockstowatch/2658/A-...at-Want-It

- Innovation Pharmaceuticals Stock May Be A Triple-Crown Winner With Brilacidin By Year End
https://seekingalpha.com/article/4088788-inno...n-year-end

- 2017 Q3 Conference Call Transcript
https://seekingalpha.com/article/4080068-inno...transcript

- 2017 Q1 Conference Call Transcript
http://seekingalpha.com/article/4023682-cellc...transcript

- Interview with New Cellceutix President Dr A Bertolino
http://seekingalpha.com/article/3988240-inter...-bertolino

- Cellceutix Pipeline Continues to Hit Milestone After Milestone
https://www.streetwisereports.com/pub/na/cell...-milestone

- A Small-Cap Biotech with Big Ideas for Acute Infections and Cancers: Cellceutix's Leo Ehrlich and Dr. Daniel Jorgensen
http://www.thelifesciencesreport.com/pub/na/a...-jorgensen

Corporate Overview

- BioCentury NewsMakers Conference https://static1.squarespace.com/static/571535...ep2017.pdf

- Drug Discovery and Therapy World Congress
https://static1.squarespace.com/static/571535...ul2017.pdf

- July 2017
https://static1.squarespace.com/static/571535...erview.pdf

Patents

- Kevetrin
https://www.google.com/patents/US8338454

- Brilacidin
https://www.sec.gov/Archives/edgar/data/13552...ex1037.htm
https://www.google.com/patents/US20160243117
https://www.google.com/patents/EP2709619A2

- Prurisol
https://www.google.com/patents/WO2013103601A1

MP Advisors Report

https://drive.google.com/file/d/0Bz15O4eaX-as...hENFk/view

Abbreviations

K – Kevetrin
B – Brilacidin
P – Prurisol
OC – ovarian cancer
ABSSSI – acute bacterial skin and skin structure infections
OM – oral mucositis
UP – ulcerative proctitis
QIDP – qualified infectious disease product

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Dont-give-up.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Volato Group Faces Merger Scrutiny Amid SOAR Deal

Updated Category News Views 2

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
Supercharged Entertainment's Big Bet in Ohio's Polaris

Updated Category News Views 2

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

Continue Reading
Three Lions Acquisition Corp: $100M IPO Hits Nasdaq

Updated Category News Views 3

Three Lions Joins the SPAC Playground The market's buzzing today as Three Lions Acquisition Corp. sauntered in with a $100M debut. Yep, they're the latest Special Purpose Acquisition Company out to net some big fish in the sports, hospitality, and real estate waters. A blank check company raising this kind of dough ain't exactly a novelty, but it never fails to turn a few...

Continue Reading
Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 2

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
K-Royal Culture Festival 2026: A Global Heritage Experience

Updated Category News Views 1

The K-Royal Culture Festival is rolling out in Fall 2026 with a flair that promises to capture the globetrotters' imaginations and then some. South Korea's signature national heritage jamboree is popping off from October 7 through October 11, 2026, at four magnificent palaces and the Jongmyo Shrine. If you're into discovering the depths of a place's history through...

Continue Reading
XTrend Speed Extends AFA Sponsorship: Strategic Moves

Updated Category News Views 0

The Ongoing Alliance Between Finance and Football Well, color me intrigued. XTrend Speed's got their foot in two worlds—a top trading platform and now four years deep into supporting the Argentine Football Association. What's it all about? Primarily, this isn't merely about splashing logos across football kits. It's about syncing prestige, global reach, and excellence....

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 3

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
TVEyes Archive+: Revolutionizing Media Intelligence

Updated Category News Views 3

TVEyes Archive+ Takes Media Intelligence to New Heights Dishing out another update here, folks. TVEyes, the media intelligence powerhouse, just kicked off something that's got the potential to change the strategic media game—they call it Archive+. This tool isn’t just plundering old tapes; we're talking nearly two damn decades worth of historical broadcasts and...

Continue Reading

Top 5 Most Recently Viewed Articles

Celltrion Showcases Promising Phase III Trial Results for CT-41 and CT-P47

Updated Category News Views 566

Celltrion's Groundbreaking Presentation at ACR Convergence 2024 Celltrion has made significant strides in biosimilar research, recently featuring compelling data at the American College of Rheumatology Convergence 2024. This event showcased their advancements with CT-P41, a biosimilar candidate of denosumab, and CT-P47, a biosimilar candidate of tocilizumab. These...

Continue Reading
How a Whale Trader Transformed a Huge Loss into Gains in Crypto

Updated Category News Views 87

Turning Losses into Profits in Cryptocurrency Trading In the volatile world of cryptocurrency, there are stories of immense gains and significant losses. One such story is that of a whale trader who experienced substantial losses in a digital asset called Dogwifhat. Despite facing a daunting challenge, this trader showed that resilience and strategic thinking can lead to...

Continue Reading
Verde and C-Twelve's Innovative Partnership for Road Sustainability

Updated Category News Views 129

Revolutionizing Road Construction with Innovative Technologies Verde Resources Inc. (OTCQB: VRDR) and C-Twelve Pty Ltd are embarking on an exciting journey together, unveiling a groundbreaking 10-year exclusive partnership that promises to reshape the landscape of sustainable road construction. A Vision for Sustainable Infrastructure This partnership aims to introduce low...

Continue Reading
Helius Medical Technologies Secures $3.7 Million in Funding

Updated Category News Views 503

Helius Medical Technologies, Inc. Announces Successful Warrant Exercise Helius Medical Technologies, Inc. (Nasdaq:HSDT), a pioneer in neurotechnology dedicated to improving the lives of individuals with neurological conditions, has recently made an exciting announcement. The company has successfully entered into agreements to exercise existing warrants for 4,971,110...

Continue Reading
Aethon United's Major Tender Offer Insights for Investors

Updated Category News Views 71

Aethon United BR LP, or simply Aethon United, is shaking things up with a fresh cash tender offer targeting its outstanding senior notes due in 2026. This play is all about tightening up their financial game, looking to boost operational agility and bolster overall fiscal health. Let’s break down what this means for noteholders and the company’s larger strategy....

Continue Reading